From growth to maturity: what founders and investors need to know about going public

MedTech Across Borders – Recent Developments in Japan and the US

Essential Antitrust #37: Antitrust in 2024: competition enforcement takes center stage

Essential Antitrust #36: The UK’s DMCC Bill – what you need to know

From chaos to control: making the case for legal project managers

MedTech x Creating System Change – Reducing clinician burnout, effectively using AI and more

Global Perspectives on Health Data Offerings and Considerations for Innovators

MedTech Diversity and Inclusion – A Conversation with Jhaymee Tynan

Essential Antitrust #25: Antitrust in 2023: 10 key themes - growing unpredictability and brand new enforcement tools

MedTech - A Conversation with Stacy Hostetler

MedTech - A Conversation with Gloria Seibert

Managing Risk in Asia #6: Managing transactional risks in life science investments in Asia

MedTech and Health Equity for Women - A Conversation with Marissa Fayer

Future trends in Medtech

Essential Antitrust #20: Innovation-driven deals: plan for success (part 2)

Essential Antitrust #19: Innovation-driven deals: plan for success (part 1)

Investing in tech: trends to watch in the year ahead

Investing in tech: regulation to disrupt tech deal-making?

Buyer beware: avoiding privacy and cyber hazards in M&A

Fintech in focus: why governance matters

Tax matters: Digital taxes and trade wars – will the OECD/G20 agreement bring tax peace?

From growth to maturity: what founders and investors need to know about going public

The keys to successful corporate venture capital investing

View from the Valley #7: The future of data privacy in the United States

Essential Antitrust #15: Focus on fintech deals: navigating a tougher regulatory environment

Asia Essential Antitrust #4: Navigating India’s competition regime, including an overview of recent cases in the tech sector.

View from the Valley #6: Should US tech companies be worried about Russia?

Fintech in focus: paying cross-border

Ransomware: what boards need to know about the Colonial Pipeline attack

The EU’s AI Regulation #1: Understanding the draft rules

Arbitration top trends: are investment treaties the answer to big tech’s problems?

Fintech in focus: is Open Banking here?

Data and cyber breaches: Part 2 – the new go-to mass claims for claimant lawyers?

Data and cyber breaches: Part 1 – the new go-to mass claims for claimant lawyers?

Tech transactions in the spotlight

Navigating the US: Part two - Dealing with the Valley

Navigating the US: Part one - Dealing with the Valley: A post-election rundown

Rethinking the supply chain #1: sustainability and digitisation in focus

Anatomy of a data breach – what really happens in a global data crisis?

What every startup should know about corporate governance

The IP mistakes founders make

Fintech in focus: digital identity

Capital raising in the time of COVID-19

View from the Valley #2: diversity, IPOs and director compensation

View from the Valley #1: the impact of COVID

International arbitration #4 - Data protection and cyber security in arbitration proceedings

TechConnect - Europe's approach to regulating artifical intelligence

Sanctions and international trade #1: sanctions trends and developments

Inside the Freshfields Hub

A global guide to data ethics

Can you own AI?

Investing in startups

How lawyers can help mitigate cyber risk

Tech IPOs - what can we expect in 2019?

The impact of EU regulation on US tech

Cyber security: our experience at the Expo

Cyber security: are you on your best behaviour

Digital transformation: the secrets of success

How to build a digital business

Data and merger control

Introducing the Freshfields digital podcast series

What's different about digital deals?